Crinetics | News & Events

PRESS RELEASES

Press Release | January 2, 2019

Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Press Release | November 3, 2018

Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Press Release | September 26, 2018

Crinetics Pharmaceuticals to Present at Leerink Partners Roundtable Series: Rare Disease & Oncology

Press Release | August 30, 2018

Crinetics Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Press Release | July 20, 2018

Crinetics Pharmaceuticals Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Press Release | July 17, 2018

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

Press Release | June 21, 2018

Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly

Press Release | June 18, 2018

Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer

Press Release | March 13, 2018

Top News: Crinetics raises $63.5 million in new funds and adds to BOD

Press Release | March 13, 2018

Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing

22 / 24

Transforming Endocrine Disease Treatment

Be the first to know about the advances we're making in endocrine-rooted care.

Email Signup